Liping Zhou PhD

Dr. Liping Zhou is currently a senior director at AstraZeneca Boston R&D Center. She is heading the Advanced Drug Delivery – Boston team, developing preclinical and clinical formulations supporting AstraZeneca's internal synthetic modality pipeline projects. Dr. Zhou has 20 years of post-PhD technical and managerial experience in research and development functions in the biotechnology/pharmaceutical industry. She has diversified expertise, especially in pre-formulation, formulation development, and drug delivery technologies, focusing on small molecules, peptides, and nucleic acids.

She has been actively involved in preclinical and clinical programs, life-cycle management, and due diligence projects in multiple therapeutic areas, as well as efficiently and strategically managing external collaborations in the US, Europe, and Asia. Dr. Zhou’s previous employment includes but is not limited to Novartis, Ipsen, and Ra Pharmaceuticals (now UCB). She co-authored more than 20 scientific publications in the leading biomedical journals and book chapters. Dr. Zhou received her Ph.D. degree in Chemistry from the University of Connecticut and her bachelor’s degree from Peking University.